4//SEC Filing
Mack David Henry 4
Accession 0001415889-24-024622
CIK 0001699382other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:44 PM ET
Size
15.5 KB
Accession
0001415889-24-024622
Insider Transaction Report
Form 4
Mack David Henry
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2024-08-13+330,000→ 330,000 totalExercise: $1.48Exp: 2034-08-13→ Common Stock (330,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-08-13−134,584→ 0 totalExercise: $28.33Exp: 2031-05-11→ Common Stock (134,584 underlying) - Award
Employee Stock Option (right to buy)
2024-08-13+384,184→ 384,184 totalExercise: $1.48Exp: 2034-08-13→ Common Stock (384,184 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-08-13−330,000→ 0 totalExercise: $5.70Exp: 2033-05-12→ Common Stock (330,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-08-13−249,600→ 0 totalExercise: $16.29Exp: 2032-02-10→ Common Stock (249,600 underlying)
Footnotes (8)
- [F1]Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.
- [F2]On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share.
- [F3]Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.
- [F4]On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share.
- [F5]One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.
- [F6]Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.
- [F7]On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share.
- [F8]One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter.
Documents
Issuer
PMV Pharmaceuticals, Inc.
CIK 0001699382
Entity typeother
Related Parties
1- filerCIK 0001341642
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:44 PM ET
- Size
- 15.5 KB